Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction
Authors:
- Jihyun KimJKJihyun Kim
- Byung Eui KimBKByung Eui Kim
- Evgeny BerdyshevEBEvgeny Berdyshev
- Irina BronovaIBIrina Bronova
- Lianghua BinLBLianghua Bin
- Jaewoong BaeJBJaewoong Bae
- Seokjin KimSKSeokjin Kim
- Hye‐Young KimHKHye‐Young Kim
- Un Ha LeeULUn Ha Lee
- Myoung Shin KimMKMyoung Shin Kim
- Hyunmi KimHKHyunmi Kim
- Jinyoung LeeJLJinyoung Lee
Open Access
Abstract
Background: Staphylococcus (S) aureus colonization is known to cause skin barrier disruption in atopic dermatitis (AD) patients. However, it has not been studied how S. aureus induces aberrant epidermal lipid composition and skin barrier dysfunction.Methods: Skin tape strips (STS) and swabs were obtained from 24 children with AD (6.0 ± 4.4 years) and 16 healthy children (7.0 ± 4.5 years). Lipidomic analysis of STS samples was performed by mass spectrometry. Skin levels of methicillin‐sensitive and methicillin‐resistant S. aureus (MSSA and MRSA) were evaluated. The effects of MSSA and MRSA were evaluated in primary human keratinocytes (HEKs) and organotypic skin cultures.Results: AD and organotypic skin colonized with MRSA significantly increased the proportion of lipid species with nonhydroxy fatty acid sphingosine ceramide with palmitic acid ([N‐16:0 NS‐CER], sphingomyelins [16:0–18:0 SM]), and lysophosphatidylcholines [16:0–18:0 LPC], but significantly reduced the proportion of corresponding very long‐chain fatty acids (VLCFAs) species (C22–28) compared to the skin without S. aureus colonization. Significantly increased transepidermal water loss (TEWL) was found in MRSA‐colonized AD skin. S. aureus indirectly through interleukin (IL)‐1β, tumor necrosis factor (TNF)‐α, IL‐6, and IL‐33 inhibited expression of fatty acid elongase enzymes (ELOVL3 and ELOVL4) in HEKs. ELOVL inhibition was more pronounced by MRSA and resulted in TEWL increase in organotypic skin.Conclusion: Aberrant skin lipid profiles and barrier dysfunction are associated with S. aureus colonization in AD patients. These effects are attributed to the inhibition of ELOVLs by S. aureus‐induced IL‐1β, TNF‐α, IL‐6, and IL‐33 seen in keratinocyte models and are more prominent in MRSA than MSSA.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
This publication has 67 references indexed in Scilit:
- Host Gene Expression Profiling and In Vivo Cytokine Studies to Characterize the Role of Linezolid and Vancomycin in Methicillin-Resistant Staphylococcus aureus (MRSA) Murine Sepsis ModelPLOS ONE, 2013
- Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitisGenome Research, 2012
- The role of fatty acid elongation in epidermal structure and functionDermato-Endocrinology, 2011
- Role of bacterial components in macrophage activation by the LAC and MW2 strains of community-associated, methicillin-resistant Staphylococcus aureusCellular Immunology, 2011
- ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesisProceedings of the National Academy of Sciences, 2010
- Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injuryProceedings of the National Academy of Sciences, 2010
- Cytokine modulation of atopic dermatitis filaggrin skin expressionJournal of Allergy and Clinical Immunology, 2007
- Loss of functional ELOVL4 depletes very long-chain fatty acids (≥C28) and the unique ω-O-acylceramides in skin leading to neonatal deathHuman Molecular Genetics, 2007
- The cornified envelope: a model of cell death in the skinNature Reviews Molecular Cell Biology, 2005
- Increased Interleukin 6 Production by T Cells Derived from Patients with Atopic DermatitisJournal of Investigative Dermatology, 1993